
    
      Co- Primary objectives:

        1. To evaluate the serologic immune response to rotavirus vaccine (sero-conversion or
           four-fold rise in rotavirus immunoglobulin A (IgA) antibodies) among Indian infants
           receiving zinc supplementation given daily for a week prior to the administration of the
           first dose through a week following the second dose of oral rotavirus vaccine compared
           to those receiving a zinc placebo.

        2. To evaluate the serologic immune response to rotavirus vaccine (sero-conversion or
           four-fold rise in rotavirus IgA antibodies) among Indian infants receiving probiotic
           supplementation given daily for a week prior to the administration of the first dose
           through a week following the second dose of oral rotavirus vaccine compared to those
           receiving a probiotic placebo.
    
  